How will that apply with covid vaccines? We know they're desperate for Good News, so the likelihood of corners being cut might seem a priori a whole lot higher than with Boeing. Hence some questions:
- I understand the Single Market provides a single regulatory framework for EU member states and friends, thus sparing pharma companies (and other developers of regulated products) a lot of red tape. Is that correct, and how far does EU approval go towards making a vaccine automatically legal/available in member countries?
- Does anyone know whether and how brexit affects this?
- Do we have mutual recognition - or something approaching it - of medicines with any other countries, such as the US?
- Is there routine jurisdiction-shopping by pharma companies seeking regulatory approval for a drug? If so, what jurisdictions are commonly favoured?